# Investigation of Akt1 behavior on gold surface from molecular dynamics insight

**Authors:** Farzane Abasi Joozdani, Mohammad Reza Amiran, Majid Taghdir

PMC · DOI: 10.1038/s41598-025-20366-2 · Scientific Reports · 2025-10-21

## TL;DR

This study explores how gold nanoparticles interact with the AKT1 protein, potentially affecting cancer signaling pathways.

## Contribution

The study reveals how gold nanoparticles influence AKT1 dynamics and conformational entropy, offering new insights into their biomedical applications.

## Key findings

- AKT1 binds to gold nanoparticles via electrostatic and hydrophobic interactions.
- Gold nanoparticles reduce AKT1 dynamics and compactness.
- Conformational entropy increases in AKT1 when bound to gold nanoparticles.

## Abstract

In the past few years, gold nanoparticles (AuNPs) have shown great roles in biomedical areas. They can interact with proteins and change their structure and function. The serine/threonine kinase AKT plays a key role in cellular processes. Therefore, the AKT protein is known as a drug target for cancer treatment. In this study, we assessed the effect of gold nanoparticles on the AKT1 protein using molecular docking and molecular dynamics simulation. The results show that the AKT1 protein binds to citrate-coated gold surface predominantly through electrostatic and hydrophobic interactions. The RMSF calculations show that the AKT1 protein in the presence of gold nanoparticles exhibits less dynamic than the free state. The presence of gold nanoparticles causes the protein to have less compactness. The linker domain in the inactive conformation, and the regulatory domain and the glycine-rich loop in the active conformation of the AKT1 protein have higher dynamics than other regions. Furthermore, free energy landscape calculations show that AKT1 protein has a more conformational entropy in complex states in two active and inactive conformations. The results show that gold nanoparticles can affect the AKT1 protein and as a result, inhibit the phosphorylation flow in the protein signaling pathway in cancer cells.

## Linked entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207]
- **Proteins:** AKT1 (AKT serine/threonine kinase 1)
- **Chemicals:** citrate (PubChem CID 31348)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** cancer (MESH:D009369)
- **Chemicals:** gold (MESH:D006046), AuNPs (-), citrate (MESH:D019343)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12540876/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12540876/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12540876/full.md

---
Source: https://tomesphere.com/paper/PMC12540876